Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Saideh Fakharzadeh, Hassan Argani, Simin Dadashzadeh, Somayeh Kalanaky, Peyman Mohammadi Torbati, Mohammad Hassan Nazaran & Abbas Basiri. (2020) BCc1 Nanomedicine Therapeutic Effects in Streptozotocin and High-Fat Diet Induced Diabetic Kidney Disease. Diabetes, Metabolic Syndrome and Obesity 13, pages 1179-1188.
Read now
Read now
Etheresia Pretorius, Natasha Vermeulen, Janette Bester, Boguslaw Lipinski & Douglas B. Kell. (2013) A novel method for assessing the role of iron and its functional chelation in fibrin fibril formation: the use of scanning electron microscopy. Toxicology Mechanisms and Methods 23:5, pages 352-359.
Read now
Read now
B Lipinski & E Pretorius. (2012) Hydroxyl radical-modified fibrinogen as a marker of thrombosis: the role of iron. Hematology 17:4, pages 241-247.
Read now
Read now
Articles from other publishers (15)
Coralie Grange, François Lux, Thomas Brichart, Laurent David, Aymeric Couturier, David E. Leaf, Bernard Allaouchiche & Olivier Tillement. (2023) Iron as an emerging therapeutic target in critically ill patients. Critical Care 27:1.
Crossref
Crossref
George J. Kontoghiorghes. (2023) Iron Load Toxicity in Medicine: From Molecular and Cellular Aspects to Clinical Implications. International Journal of Molecular Sciences 24:16, pages 12928.
Crossref
Crossref
Zitong Zhu, Xinchen Liu, Penghui Li, Huan Wang, Yanjie Zhang, Mengmeng Liu & Jinsong Ren. (2023) Renal Clearable Quantum Dot–Drug Conjugates Modulate Labile Iron Species and Scavenge Free Radicals for Attenuating Chemotherapeutic Drug-Induced Acute Kidney Injury. ACS Applied Materials & Interfaces 15:18, pages 21854-21865.
Crossref
Crossref
Aniruddha Adhikari, Susmita Mondal, Tanima Chatterjee, Monojit Das, Pritam Biswas, Ria Ghosh, Soumendra Darbar, Hussain Alessa, Jalal T. Althakafy, Ali Sayqal, Saleh A. Ahmed, Anjan Kumar Das, Maitree Bhattacharyya & Samir Kumar Pal. (2021) Redox nanomedicine ameliorates chronic kidney disease (CKD) by mitochondrial reconditioning in mice. Communications Biology 4:1.
Crossref
Crossref
Vladimir Camarena, Tyler C. Huff & Gaofeng Wang. (2021) Epigenomic regulation by labile iron. Free Radical Biology and Medicine 170, pages 44-49.
Crossref
Crossref
Saideh Fakharzadeh, Hassan Argani, Peyman Mohammadi Torbati, Simin Dadashzadeh, Somayeh Kalanaky, Mohammad Hassan Nazaran & Abbas Basiri. (2020) DIBc nano metal-organic framework improves biochemical and pathological parameters of experimental chronic kidney disease. Journal of Trace Elements in Medicine and Biology 61, pages 126547.
Crossref
Crossref
Peter A. McCullough & Claudio Ronco. 2019. Critical Care Nephrology. Critical Care Nephrology
664
670.e3
.
Young Ah Seo, Ruvin Kumara, Herbert Wetli & Marianne Wessling-Resnick. (2016) Regulation of divalent metal transporter-1 by serine phosphorylation. Biochemical Journal 473:22, pages 4243-4254.
Crossref
Crossref
Fabiola Del Greco M.Luisa Foco, Irene Pichler, Philipp Eller, Kathrin Eller, Beben Benyamin, John B. Whitfield, Peter P. Pramstaller, John R. Thompson, Cristian Pattaro & Cosetta Minelli. (2016) Serum iron level and kidney function: a Mendelian randomization study. Nephrology Dialysis Transplantation, pages gfw215.
Crossref
Crossref
Gillipsie Minhas, Shweta Modgil & Akshay Anand. (2014) Role of iron in ischemia-induced neurodegeneration: mechanisms and insights. Metabolic Brain Disease 29:3, pages 583-591.
Crossref
Crossref
Chunbo Zou, Rujuan Xie, Yushi Bao, Xiaogang Liu, Manshu Sui, Suhong M, Shuang Li & Huiqing Yin. (2013) Iron chelator alleviates tubulointerstitial fibrosis in diabetic nephropathy rats by inhibiting the expression of tenascinC and other correlation factors. Endocrine 44:3, pages 666-674.
Crossref
Crossref
Claudio Ronco, Mariantonietta Cicoira & Peter A. McCullough. (2012) Cardiorenal Syndrome Type 1. Journal of the American College of Cardiology 60:12, pages 1031-1042.
Crossref
Crossref
Delu Song, Ying Song, Majda Hadziahmetovic, Yong Zhong & Joshua L. Dunaief. (2012) Systemic administration of the iron chelator deferiprone protects against light-induced photoreceptor degeneration in the mouse retina. Free Radical Biology and Medicine 53:1, pages 64-71.
Crossref
Crossref
Anatole Besarab & Daniel W. Coyne. (2010) Iron supplementation to treat anemia in patients with chronic kidney disease. Nature Reviews Nephrology 6:12, pages 699-710.
Crossref
Crossref
PETER A. McCULLOUGH. (2010) Editorial: Contrast‐Induced Acute Kidney Injury: Shifting from Elective to Urgent Coronary Intervention. Journal of Interventional Cardiology 23:5, pages 467-469.
Crossref
Crossref